Pioneering work by Dr. Srivastava demonstrated that several HSPs (HSP7, gp96, and HSP90) can induce immunity against autologous tumor preparations from which these HSPs had been isolated [39,40]. This evidence concerns the gene HSP90B1 and neoplasm.